Shoichi Harada
Clinical Development Department
Nippon Organon K. K.
Dojima Avanza 14F
1-6-20 Dojima
Japan
Name/email consistency: high
- Biopharmaceutical considerations on antihistamine effects of topically administered emedastine. Harada, S., Nakada, Y., Yamashita, F., Hashida, M. J. Pharm. Sci (2005)
- Estimation of in vivo percutaneous absorption of emedastine from bile excretion data using a deconvolution method. Harada, S., Yamashita, F., Hashida, M. Drug Metab. Pharmacokinet. (2005)









